Microbiome sequencing services market to reach $5.5b by 2030

A primary driver is the growing interest in the human microbiome.

The global microbiome sequencing services market is projected to reach $5.5b by 2030 at a compound annual growth rate of 18.1%, according to Research and Markets.

The sector’s expansion is attributed to the rising demand for personalised medicine, increased investments, and advancements in sequencing methods.

Meanwhile, a primary driver is the growing interest in the human microbiome and its role in health and disease.

“As research continues to uncover links between microbiome composition and various health conditions, there is increasing demand for microbiome sequencing in both clinical and research settings,” the report said.

Furthermore, the rise of direct-to-consumer microbiome testing has further boosted public interest in personal microbiome analysis, contributing to growth within the consumer health and wellness sector.